申请人:Kowa Co., Ltd.
公开号:US06432957B1
公开(公告)日:2002-08-13
A piperazine compound represented by formula (1):
wherein X is —CH2—, —C(O)— or —CH(CH3)—; R1 is a hydrogen atom or alkyl group; and R2 is a hydrogen atom, alkyl group, hydroxyalkyl group, arylalkyl group, heteroarylalkyl group, carboxyalkyl group, carboxamidoalkyl group, aminoalkyl group or guanidinoalkyl group; an acid-addition salt thereof, or a hydrate thereof. The compound has excellent inhibitory effects on both cell adhesion and cell infiltration and is useful for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation.
一种由化学式(1)表示的哌嗪化合物:
其中X为—CH2—、—C(O)—或—CH(CH3)—;R1为氢原子或烷基基团;R2为氢原子、烷基基团、羟基烷基基团、芳基烷基基团、杂环芳基烷基基团、羧基烷基基团、羧胺基烷基基团、氨基烷基基团或胍基烷基基团;其酸加合盐,或其水合物。该化合物对细胞粘附和细胞浸润均具有出色的抑制作用,并可用于预防或治疗过敏、哮喘、风湿病、动脉硬化和炎症等疾病。